Mariner Investment Group’s Pear Therapeutics, Inc. Class A Common Stock PEAR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-35,000
Closed -$348K 201
2021
Q3
$348K Buy
35,000
+15,000
+75% +$149K 0.94% 32
2021
Q2
$198K Buy
+20,000
New +$198K 0.43% 71